Friends Research Institute
Los Angeles, California, 90025, United States
NCT Number: NCT00000343
The purpose of this study is to identify the neurophysiologic indicators of cocaine or methamphetamine use and withdrawal, to examine the relationship between subjects' reports of depression, craving, and stimulant use, and neurophysiologic measures, and to identify neurophysiologic measures which can be used to identify new treatments for stimulant dependence.
Looking for future studies?
Notify Me21 year–50 year
All sexes
Interventional
Phase 4
Los Angeles, California, 90025, United States
By Incorporating QEEG into clinical trails, the plan is to develop physiologic markers of treatment efficacy, and to aid in the identification of effective treatments.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
M/F ages 21-50. Meet DSM-IV criteria for cocaine dependence. Agree to conditions of the study and sign informed consent.
Exclusion criteria
Psychiatric disorder that requires medication therapy. History of seizures. Pregnant and/or nursing women. Dependence on ETOH or benzodiazepines or other sedative/hypnotics. Acute hepatitis. Other medical conditions that deem participation to be unsafe.
National Institute on Drug Abuse (NIDA)
Nih
Brain Changes in Stimulant Dependent Subjects
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06629493
Alcohol Use Disorder (AUD), Alcohol-Related Disorders
Gijón, Principality of Asturias, Spain
View Trial DetailsNCT03866694
Behavior, Chemically-Induced Disorders
Boston, Massachusetts, United States
View Trial DetailsNCT05998005
Behavior, Behavior, Addictive
Bonners Ferry, Idaho, United States
View Trial DetailsNCT01117753
Anxiety Disorder, Anxiety Disorders
Charleston, South Carolina, United States
View Trial Details